Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• WHO. Coronavirus Disease (COVID-19) Pandemic; 2020.
   Google Scholar
• Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020:ciaa325. doi:10.1093/cid/ciaa325.
   PubMed Web of Science ®Google Scholar
• Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–14621. doi:10.1128/JVI.79.23.14614-14621.2005
   PubMed Web of Science ®Google Scholar
• Roberts A, Vogel L, Guarner J, et al. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol. 2005;79(1):503–511. doi:10.1128/JVI.79.1.503-511.2005
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan L-M, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834–838. doi:10.1038/s41586-020-2342-5
   PubMed Web of Science ®Google Scholar
• Warner BM, Safronetz D, Kobinger GP. Syrian hamsters as a small animal model for emerging infectious diseases: advances in immunologic methods. Adv Exp Med Biol. 2017;972:87–101. doi:10.1007/5584_2016_135
   PubMed Web of Science ®Google Scholar
• Brocato RL, Principe LM, Kim RK, et al. Disruption of adaptive immunity enhances disease in SARS-CoV-2 infected Syrian hamsters. bioRxiv. 2020. doi:10.1101/2020.06.19.161612
   Google Scholar
• Lee AC-Y, Zhang AJ, Chan JF-W, et al. Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters. Cell Rep Med. 2020:100121. doi:10.1016/j.xcrm.2020.100121.
   PubMedGoogle Scholar
• Monchatre-Leroy E, Lesellier S, Wasniewski M, et al. Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2. bioRxiv. 2020. doi:10.1101/2020.09.24.311977
   Google Scholar
• Bao L, Deng W, Huang B, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583(7818):830–833. doi:10.1038/s41586-020-2312-y
   PubMed Web of Science ®Google Scholar
• Winkler ES, Bailey AL, Kafai NM, et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020. doi:10.1038/s41590-020-0778-2
   Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi:10.3389/fimmu.2020.00827
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020. doi:10.1016/s2213-2600(20)30076-x
   Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/s0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Pedersen SF, Ho Y-C. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202–2205. doi:10.1172/JCI137647
   PubMed Web of Science ®Google Scholar
• Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33(6):1007–1014. doi:10.1038/s41379-020-0536-x
   PubMed Web of Science ®Google Scholar
• Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. 2020;159(1):367–370. doi:10.1053/j.gastro.2020.03.055
   PubMed Web of Science ®Google Scholar
• Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128–2130.e2122. doi:10.1016/j.cgh.2020.04.040
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718. doi:10.1126/science.abc6027
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27(6):883–890.e882. doi:10.1016/j.chom.2020.04.017
   PubMed Web of Science ®Google Scholar
• Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–1045.e1039. doi:10.1016/j.cell.2020.04.026
   PubMed Web of Science ®Google Scholar
• Kulkarni AV, Kumar P, Tevethia HV, et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52(4):584–599. doi:10.1111/apt.15916
   PubMed Web of Science ®Google Scholar
• Yadav DK, Singh A, Zhang Q, et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70(4):807. doi:10.1136/gutjnl-2020-322072
   PubMed Web of Science ®Google Scholar
• Kumar-M P, Mishra S, Jha DK, et al. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int. 2020;14(5):711–722. doi:10.1007/s12072-020-10071-9
   PubMed Web of Science ®Google Scholar
• Paliogiannis P, Zinellu A. Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis. Liver Int. 2020;40(7):1787–1788. doi:10.1111/liv.14477
   PubMed Web of Science ®Google Scholar
• Bruno G, Fabrizio C, Santoro CR, Buccoliero GB. Pancreatic injury in the course of coronavirus disease 2019: a not-so-rare occurrence. J Med Virol. 2021;93(1):74–75. doi:10.1002/jmv.26134
   PubMed Web of Science ®Google Scholar
• McNabb-Baltar J, Jin DX, Grover AS, et al. Lipase elevation in patients with COVID-19. Am J Gastroenterol. 2020;115(8):1286–1288. doi:10.14309/ajg.0000000000000732
   PubMed Web of Science ®Google Scholar
• Barlass U, Wiliams B, Dhana K, et al. Marked elevation of lipase in COVID-19 disease: a Cohort Study. Clin Transl Gastroenterol. 2020;11(7):e00215–e00215. doi:10.14309/ctg.0000000000000215
   PubMedGoogle Scholar
• Wang Y, Liu S, Liu H, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807–816. doi:10.1016/j.jhep.2020.05.002
   PubMed Web of Science ®Google Scholar
• Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590–592. doi:10.1056/NEJMc2011400
   PubMed Web of Science ®Google Scholar